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1
Peripheral neuropathy and insensate limbs and digits cause
significant morbidity in diabetic individuals. Previous studies
showed that deletion of the receptor for advanced end-glycation
products (RAGE) in mice was protective in long-term diabetic
neuropathy. Here, we tested the hypothesis that RAGE sup-
presses effective axonal regeneration in superimposed acute
peripheral nerve injury attributable to tissue-damaging inflamma-
tory responses. We report that deletion of RAGE, particularly in
diabetic mice, resulted in significantly higher myelinated fiber
densities and conduction velocities consequent to acute sciatic
nerve crush compared with wild-type control animals. Consistent
with key roles for RAGE-dependent inflammation, reconstitution
of diabetic wild-type mice with RAGE-null versus wild-type bone
marrow resulted in significantly improved axonal regeneration
and restoration of function. Diabetic RAGE-null mice displayed
higher numbers of invading macrophages in the nerve segments
postcrush compared with wild-type animals, and these macro-
phages in diabetic RAGE-null mice displayed greater M2 polar-
ization. In vitro, treatment of wild-type bone marrow–derived
macrophages with advanced glycation end products (AGEs),
which accumulate in diabetic nerve tissue, increased M1 and de-
creased M2 gene expression in a RAGE-dependent manner.
Blockade of RAGE may be beneficial in the acute complications
of diabetic neuropathy, at least in part, via upregulation of re-
generation signals. Diabetes 62:931–943, 2013
D
iabetes leads to the development of multiple
complications (1–3). Peripheral neuropathy
affects 30–50% of all diabetic patients (4–6).
Individuals with diabetes are more vulnerable
to superimposed thermal and pressure injuries (7–10).
Diabetic individuals exposed to either topical application
of capsaicin or intracutaneous excision axotomy (punch
skin biopsy) displayed a reduction in regenerative rate,
even without evidence of neuropathy, and reduced axonal
regenerative sprouting and blood vessel growth, re-
spectively, compared with nondiabetic control subjects
(11,12). Studies of diabetic animals reported a delay of
axonal regeneration after acute sciatic nerve crush com-
pared with nondiabetic mice (13). Evidence suggests that
enhanced accumulation of advanced glycation end
products (AGEs) may be an important contributing
mechanism to the pathogenesis of diabetes complications
(14,15). AGEs are a heterogeneous group of molecules that
impact cellular properties and gene expression via specific
receptors such as receptor for advanced end-glycation
product (RAGE) (16–18). RAGE, a pattern recognition
receptor, also interacts with multiple members of the
proinflammatory S100/calgranulin family and with high-
mobility group box 1 protein (HMGB1); both classes of
molecules are implicated in inflammation and cellular mi-
gration (19,20). These non-AGE ligands may be released by
dying cells, and evidence suggests that although RAGE is
not intimately involved in innate immune responses, its
upregulation and activation by these ligands contribute to
sustained inflammation and suppression of repair (21,22).
These considerations prompted us to hypothesize that
RAGE action in superimposed acute injury to the periph-
eral nerve, particularly in diabetes, attenuates neurite
outgrowth and axonal regeneration via tissue-damaging
inflammatory mechanisms. We subjected wild-type (WT)
and homozygous RAGE-null mice to acute sciatic nerve
crush to dissect the specific contribution of bone marrow
RAGE expression. We also subjected WT mice to lethal
irradiation and performed reconstitution with bone mar-
row expressing or devoid of RAGE.
RESEARCH DESIGN AND METHODS
Animals. Eight-week-old male C57/BL6 WT mice (Jackson Laboratories, Bar
Harbor, ME) and homozygous RAGE-null mice were used in the study. All
animals were housed in a barrier animal facility with 12-h light cycle and were
fed regular chow diet (#2918; Harlan Teklad Diets). Certain mice were rendered
diabetic with the intraperitoneal injection of streptozotocin (5 days, 50 mg/kg in
citrate buffer, 100 mmol/L, pH 4.5; Sigma). Nondiabetic control mice were
injected with an equal volume of vehicle. To determine the diabetes status of the
animals, blood glucose was measured 7 days after the first streptozotocin in-
jection and then every third week for the duration of the experiment and before
killing using a Freestyle blood glucose meter (Abbott; Almeda, CA). Animals
with a blood glucose level .13 mmol/L (260 mg/dL) were considered diabetic
and were used for further experiments. Mean body weight, blood glucose
levels, and plasma insulin levels (Alpco Diagnostics, Salem, NH) are shown
(Supplementary Table 1). All animal procedures were approved by the Co-
lumbia University and New York University Institutional Animal Care and Use
Committees and were performed in accordance with the National Institute of
Health Animal Care Guidelines.
Nerve crush. Two months after the confirmation of the diabetes status, ani-
mals were subjected to unilateral sciatic nerve crush as described (23,24).
Nerve conduction velocity. Nerve conduction velocity tests were performed
as described (2,3) and according to the Diabetes Complications Consortium
Nerve Conduction protocol (www.diacomp.org). Mice were intraperitoneally
anesthetized with ketamine/xylazine. Body temperature was monitored with
a dermal probe and maintained at 37°C with a heating lamp/water heating pad,
and skin temperature was maintained at 34°C. A Nicolet Viking II computer-
ized electromyography system was used to stimulate and record all studies
(Nicolet Biomedical, Madison, WI).
Myelin fiber density, axonal caliber, and endoneurial vessels
quantification. Intact and lesioned sciatic nerves were collected 21 days
after surgery. After tissue preparation, embedding, and cutting, cross-sections
were prepared and stained with toluidine blue. The myelinated fiber density,
From the 1Diabetes Research Program, Department of Medicine, New York
University Langone Medical Center, New York, New York; the 2Department
of Science, Borough of Manhattan Community College–City University of
New York, New York, New York; and the 3Department of Neurology, Co-
lumbia University Medical Center, New York, New York.
Corresponding author: Ann Marie Schmidt, annmarie.schmidt@nyumc.org, or
Judyta Juranek, judyta.juranek@nyumc.org.
Received 16 May 2012 and accepted 1 September 2012.
DOI: 10.2337/db12-0632
This article contains Supplementary Data online at http://diabetes
.diabetesjournals.org/lookup/suppl/doi:10.2337/db12-0632/-/DC1.
 2013 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for profit,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
diabetes.diabetesjournals.org DIABETES, VOL. 62, MARCH 2013 931
ORIGINAL ARTICLE
axonal caliber, and endoneurial vessels quantification was performed using
NIH ImageJ 7.1 with Cell Counter plug-in. Two full-size cross-sections of distal
sciatic nerve fascicule from each group were analyzed. Within one cross-
section, centrally located regions of interest (ROI), 200 mm2, were selected
for quantification to ensure proper counting methodology, as described
(25–29).
RAGE ligand immunohistochemical distribution, macrophage infiltration,
and characterization. Sciatic nerve fragments fromunlesioned and distal sciatic
nerve fragments from the lesioned animals were collected 7 (macrophages) and
21 (RAGE/ligand distribution) days after surgery. Immunohistochemistry was
performed using goat anti-human RAGE (1:100; Genetex, Irvine, CA), rabbit anti-
HMGB1, anti-carboxymethyl lysine (CML; 1:100; Abcam, Cambridge, MA), anti-
Muc1, anti-S100 (1:100; Abcam), and mouse anti-CD31 (Fitzgerald, Acton, MA).
Macrophage infiltration (total number of macrophages per ROI) was determined
using rat polyclonal F4/80 (1:100; Abcam) and/or rat polyclonal CD68 (1:100;
Abcam, Cambridge, MA); macrophage phenotype, proinflammatory M1 markers
rabbit anti-CD86 and iNOS (1:100; Abcam), M2 markers rabbit anti-Arg1 and anti-
CD163 (1:100; Abcam), and quantificationwere performed.Oil-Red-O stainingwas
performed on sciatic nerve longitudinal sections (American MasterTech, Lodi,
CA) according to the manufacturer’s instructions. The area of staining was cal-
culated using ImageJ (30,31). Note that all images related to immunohisto-
chemistry or special stains are reproduced and enlarged in the Supplementary
Data.
Bone marrow transplantation. Six-week-old WT mice were irradiated twice
in 3- to 4-h intervals with a 600-rad dose from a 137Cs source (JL Shepherd Mark
I Irradiator). Approximately 3 h after second irradiation, mice were anes-
thetized with isoflurane and intraorbitally injected with the bone marrow
suspension, which was prepared by flushing the femora and tibiae from WT
and RAGE-null mice, resuspended in Hank’s balanced salt solution to a final
concentration of 5 3 106 cells/mL. One month after the bone marrow trans-
plantation, mice were rendered diabetic or control, and 2 months later they
were subjected to unilateral sciatic nerve crush injury.
Macrophage cell cultures: quantitative mRNA PCR analysis of
macrophage phenotype in vivo. Bone marrow–derived macrophages
(BMDMs) were obtained from 6-week-old WT or RAGE-null mice and exposed
to low glucose (5.5 mmol/L D-glucose) or high glucose (25 mmol/L D-glucose),
or carboxymethyl lysine (CML) human serum albumin (AGE) (100 mg/mL),
a generous gift from Dr. Eric Boulanger, for the last 48 h of the 7-day time
course. Total RNA was isolated and quantitative real-time PCR was performed.
The primers CD86 (Mm00444543_m1) and Arg1 (Mm00475988_m1) and probe
mixture were purchased from Applied Biosystems (Applied Biosystems,
Branchburg, NJ). Data were calculated by 22DDCt method (32) and expressed
as the fold increase over the indicated controls (designated as 1) in each
figure.
Statistical analysis. Statistical analysis was performed using Graphpad InStat
(Graphpad, La Jolla, CA). All values are presented as mean 6 SEM. The sta-
tistical significance of differences (P , 0.05) was evaluated by one-way
ANOVA with Tukey post hoc and followed by two-tailed t test (for within-
group comparison).
RESULTS
RAGE deficiency facilitates axonal regeneration in
the acutely injured diabetic nerve: pathological and
functional studies. We probed the effects of global
RAGE deficiency in mice subjected to acute sciatic nerve
injury. Morphological analysis of unlesioned nerves
revealed no significant differences (Fig. 1A–E). Twenty-
one days postcrush at the site distal to injury, the num-
ber of myelinated fibers per mm2 was reduced by nearly
50% compared with baseline, and a significant difference
between WT nondiabetic and diabetic mice was ob-
served (Fig. 1E and J; P , 0.05). Compared with diabetic
WT mice postcrush, diabetic RAGE-null mice displayed
significantly higher myelinated fiber density (Fig. 1J;
P , 0.05).
To establish the impact of diabetes and RAGE on func-
tional responses to sciatic nerve crush, we assessed motor
and sensory conduction velocities. At baseline, motor and
sensory nerve conduction velocity studies revealed no
significant differences (Fig. 1K and L). Postcrush, com-
pared with WT nondiabetic mice, diabetic mice displayed
significantly lower sensory (Fig. 1M; P , 0.001) and motor
(Fig. 1N; P , 0.05) conduction velocities. Significantly
higher sensory and motor conduction velocities were ob-
served between diabetic WT and diabetic RAGE-null mice
Fig. 1M, N, respectively; P , 0.05).
Distribution of RAGE and its ligands after acute
injury to the peripheral nerve. We next studied RAGE
and RAGE ligand expression 21 days after injury. Prom-
inent RAGE staining was observed in WT nerves (not
RAGE-null; not shown). In both nondiabetic and diabetic
WT mice, crush injury was associated with a significant
increase in RAGE expression (Fig. 2A–C; P, 0.05 and P,
0.001, respectively). RAGE expression in the crushed di-
abetic nerve was significantly higher than that observed in
the crushed nondiabetic nerve (Fig. 2A–C; P , 0.001).
RAGE expression colocalized to perineurial elements
(Muc1), blood vessels (CD31), and Schwann cells (S100) in
the regenerating nerve (Supplementary Fig. 1).
To determine RAGE ligand distribution, we quantified
the number of CML-AGE and HMGB1-positive fibers in
control and diabetic nerves at baseline and 21 days post-
crush. Immunofluorescence staining revealed significantly
higher numbers of immunopositive fibers for HMGB1 and
CML-AGE at baseline between WT diabetic compared with
nondiabetic nerve (Fig. 2F–I, respectively; P , 0.05).
Compared with WT diabetic mice, RAGE-null diabetic
mice displayed significantly lower CML-AGE–expressing
fibers at baseline (Fig. 2G–I; P , 0.05). In all mice tested,
HMGB1 and CML-AGE–positive fibers were two-fold to
three-fold higher in the postcrushed nerve compared with
the uninjured nerve, irrespective of the presence or ab-
sence of RAGE or the diabetic state (Fig. 2D–I).
Diabetes and RAGE-dependent regeneration in sciatic
nerve crush. In parallel with reduced nerve fiber re-
generation, diabetes resulted in a significant decrease in
endoneurial vessels and regenerating axons at the crush
side on day 21 (P , 0.01), which was significantly im-
proved by RAGE deletion (P , 0.05) (Fig. 3A–D). Oil-
Red-O staining of nerve segments on day 21 postcrush
was significantly lower in diabetic RAGE-null mice
compared with WT diabetic mice (Fig. 3E–H).
Macrophage infiltration in sciatic nerve tissue
postcrush: effect of diabetes and RAGE. These data
suggested that Wallerian degeneration and inflammatory
mechanisms were impaired in diabetes and restored, at
least in part, by RAGE deletion. To further interrogate this
hypothesis, we determined macrophage infiltration in the
peripheral nerve at three distinct sites (Supplementary
Fig. 2) 7 days postsurgery, previously established as an
important time point in the postcrush inflammatory re-
sponse (33) (Fig. 4A–G). On the crushed side, in WT mice,
diabetes resulted in a significant increase in total number
of F4/80-positive macrophages per ROI (Fig. 4G; P , 0.05).
The RAGE-null diabetic crush side displayed a trend to-
ward higher number of F4/80-positive macrophages per
ROI compared with the diabetic WT (Fig. 4G). In the
perineurium, although diabetes did not affect the number
of F4/80-positive macrophages per ROI, RAGE-null non-
diabetic and RAGE-null diabetic tissue displayed signifi-
cantly higher F4/80-positive macrophages per ROI
compared with their respective WT controls (Fig. 4G; P ,
0.001). At the distal side, in WT mice, diabetes resulted in
a significant increase in F4/80-positive macrophages per
ROI compared with the nondiabetic condition (Fig. 4G;
P , 0.05). There were significantly higher F4/80-positive
macrophages in the ROI in the diabetic compared with
the nondiabetic RAGE-null tissue (Fig. 4G; P , 0.05). At
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FIG. 1. Deletion of RAGE in diabetic mice restores effective axonal regeneration and improves nerve conduction velocity after acute sciatic nerve
crush. Histological analysis shows sciatic nerve myelinated fibers 21 days after acute injury in nondiabetic and diabetic mice. A–E: Unlesioned
nerve at baseline. F–J: Crushed nerve 21 days after surgery. Semithin sections reveal a significant difference in number of myelinated fibers per
mm
2
between WT and RAGE-null diabetic mice, indicating that RAGE deletion is beneficial for nerve regeneration in chronic hyperglycemia after
injury. Scale bar: 50 mm2, n = 9 mice per group. K–N: Nerve conduction velocity (NCV) studies in unlesioned nerve at baseline (K, L) and acutely
injured (M, N) nerve 21 days postcrush were performed. NCV analysis indicated that although there were no baseline differences, conduction
velocity was significantly improved in RAGE-null diabetic mice compared with their WT diabetic counterparts; n = 15 mice per group.
J.K. JURANEK AND ASSOCIATES
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FIG. 2. Expression of RAGE and its ligands in diabetic peripheral nerve: baseline and postcrush injury. The indicated mouse groups were subjected
to acute sciatic nerve crush injury and the indicated staining performed in (A, B, D, E, G, and H). A–C: RAGE in the sciatic nerve tissue 21 days
postcrush injury. D–F: HMGB1 in the sciatic nerve tissue 21 days postcrush injury. G–I: CML-AGE in the sciatic nerve tissue 21 days postcrush
injury. Similar staining was performed at baseline uncrushed state (not shown) and the results were subjected to quantification as illustrated by
open bars; filled bars reflect crushed state. Scale bar: 100 mm; n = 5 mice per group. (A high-quality digital representation of this figure is available
in the online issue.)
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FIG. 3. Morphometric analysis of sciatic nerve regeneration. Number of endoneurial vessels and axonal caliber of regenerating axons were
quantified in crushed sciatic nerve section of nondiabetic and diabetic mice 21 days postsurgery (A–D). Magnified images show endoneurial vessels
(arrows) and size of regenerating axons (A, B), scale bar 25 mm. The number of vessels was significantly lower in the WT diabetic group as
compared with its counterpart, and improved by RAGE deletion in diabetes (C). The shortest caliber of regenerating axons was noticed in the
diabetic WT group (D); n = 9 per group. Oil-Red-O staining was performed on longitudinal nerve sections 7 and 21 days postsurgery (E–H). On day
7 (E, G), the most abundant staining was observed for the RAGE-null diabetic group, whereas on day 21 (F, H) the largest area of staining was
observed for WT diabetic group. Scale bar: 50 mm, n = 5. (A high-quality digital representation of this figure is available in the online issue.)
J.K. JURANEK AND ASSOCIATES
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FIG. 4. Macrophage infiltration and polarization in diabetes and crush injury: effect of RAGE. The indicated groups of mice were subjected to
diabetes or nondiabetes state; on day 7 after injury, tissue was retrieved and the indicated immunostaining experiments were performed as
follows. A–D: Immunofluorescence staining for F4/80 (red) and DAPI (nuclei) staining of sciatic nerve cross-section in the indicated mouse groups
7 days after injury. Scale bar: 50 mm. E and F: Representative images of sciatic nerve cross-sections multistained for RAGE (red) and F4/80 (green)
and DAPI (blue). Scale bar 25 mm. G: Statistical analysis of macrophage infiltration at three different sections of the nerve. Results are reported as
total macrophage number per ROI as determined by F4/80 staining. H and I: Invading macrophages were stained for M1 and M2 markers (M1,
CD86, and iNOS) and (M2, Arg1, and CD206). H: Results are depicted as the percent of total macrophages costained for individual markers. I:
Results for M1 and M2 markers are depicted by setting the WT nondiabetic condition as 100% for reference and all other groups compared with this
condition; n = 6 mice per condition. (A high-quality digital representation of this figure is available in the online issue.)
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baseline without crush, there were no significant differ-
ences in macrophage numbers in sciatic nerve tissue
among all groups (Supplementary Fig. 3).
M1- and M2-inflammatory macrophage polarization:
the impact of diabetes and RAGE. We next quantified
the expression of prototypical M1 compared with M2
markers after crush because in general, these markers are
associated with proinflammatory compared with re-
parative signatures, respectively (34,35). Nerve tissue dis-
tal to the site of crush was stained for F4/80 and M1 and
M2 macrophage markers, and the data were analyzed by
assessing the percentage of F4/80-positive macrophages
(total macrophage number) double-stained for respective
markers per ROI in each experimental condition. In this
way, we were able to account for differences in total
numbers of macrophages per condition. We tested CD86
and iNOS as prototypical M1 markers and Arg1 and
CD206 as prototypical M2 markers. The percentage of
CD86+ macrophages was significantly higher in diabetic
compared with nondiabetic WT mice (Fig. 4H; P , 0.001);
a trend was noted for percentage of macrophages staining
positively for iNOS in WT diabetic vs. nondiabetic mice
(Fig. 4H). In diabetic RAGE-null mice, the percentage of
CD86+ macrophages was significantly lower than that ob-
served in the diabetic WT (Fig. 4H; P , 0.001). Similar
trends were noted for iNOS+ macrophages. There were no
differences between WT compared with RAGE-null per-
centage of CD86+ macrophages, or iNOS+ macrophages in
the nondiabetic groups (Fig. 4H).
Analysis of M2 markers revealed a different pattern.
There was a significant increase in percentage of Arg1+
macrophages in diabetic compared with nondiabetic WT
mice (Fig. 4H; P , 0.05). However, in diabetic RAGE-null
mice, a trend toward higher percentage of Arg1+ macro-
phages was observed compared with the WT diabetic mice
(Fig. 4H). In the nondiabetic state, there were no differ-
ences in Arg1 between WT and RAGE-null mice (Fig. 4H).
In the case of CD206, we found a trend toward increased
percentage of CD206+ macrophages in diabetic compared
with nondiabetic WT mice (Fig. 4H), and a significantly
higher percentage of CD206+ macrophages was found in
the diabetic RAGE-null compared with the diabetic WT
mice (Fig. 4H; P , 0.05). Taken together, the diabetic
RAGE-deficient state was notable for higher percentage of
M2 macrophage markers compared with the diabetic WT
mice, and reduced percentage of CD86+ M1 markers
compared with WT diabetic mice postcrush.
Data were also analyzed by setting the total absolute
number of M1- or M2+-expressing cells in the WT non-
diabetic state as 100%; similar results and conclusions
were obtained (Fig. 4I).
Effect of bone marrow RAGE expression on the
response to nerve crush: pathological and functional
studies. To test the specific role of bone marrow RAGE
expression, we subjected WT mice to lethal irradiation and
reconstitution with RAGE-null or WT bone marrow. Four
weeks after bone marrow transplantation, mice were
rendered diabetic or control, and nerve crush was per-
formed 2 months later. There were no differences in my-
elinated fiber density at baseline (Fig. 5A–E). However,
diabetes resulted in significantly lower myelinated fiber
density in WT recipients of WT bone marrow postcrush
(Fig. 5F–J; P , 0.05). A statistically significantly higher
number of myelinated fibers was observed between RAGE-
null compared with WT donor bone marrow in WT diabetic
recipient mice postcrush (Fig. 5F–J; P , 0.05); no
significant differences were observed in the nondiabetic
state between RAGE-expressing compared with RAGE-
null bone marrow (Fig. 5F–J).
No baseline differences in sensory or motor conduction
velocities were observed between recipients of WT or
RAGE-null bone marrow in the nondiabetic or diabetic
states (Fig. 5K and L). 21 days postcrush, in the diabetic
state, WT mice reconstituted with WT bone marrow
revealed a significant reduction in both sensory and motor
conduction velocities (Fig. 5M, P , 0.05; and Fig. 5N, P ,
0.001). Whereas there were no differences between con-
duction velocities in WT recipients of WT compared with
RAGE-null bone marrow in the nondiabetic state, there
was a trend toward higher sensory nerve conduction ve-
locity in diabetic RAGE-null mice compared with diabetic
WT mice (Fig. 5M) and a statistically significant increase in
motor conduction velocity in WT diabetic recipients re-
ceiving RAGE-null compared with WT bone marrow (Fig.
5N; P , 0.05).
Macrophage infiltration in sciatic nerve tissue
postcrush: effect of RAGE expression in bone
marrow. We then probed the effect of RAGE expression
in the bone marrow on macrophage infiltration postcrush
(Fig. 6A–E). Whereas in the nondiabetic state there was no
effect of bone marrow RAGE expression on the numbers
of F4/80-positive cells per ROI on the crush side (Fig. 6E,
left), a significantly higher number of F4/80-positive mac-
rophages was observed in WT nondiabetic recipients of
RAGE-null compared with WT bone marrow in the peri-
neurium (Fig. 6E, right; P , 0.01). In the diabetic state, on
both the crush side and the perineurium, diabetic recipi-
ents of RAGE-null compared with WT bone marrow dis-
played significantly higher numbers of macrophages (Fig.
6E, left and right; P , 0.01 and P , 0.05, respectively). At
baseline without crush, there were no significant differ-
ences in macrophages in sciatic nerve tissue among all
groups (Supplementary Fig. 4).
Next, we tested the percentage of F4/80-positive mac-
rophages double-stained for M1 markers. The percentage
of CD86+ and percentage of iNOS+ macrophages did not
differ between diabetic compared with nondiabetic WT
recipient mice receiving WT donor bone marrow. The
percentage of CD86+ and the percentage of iNOS+ mac-
rophages were significantly higher in WT diabetic recipi-
ents receiving RAGE-null compared with WT donor bone
marrow (Fig. 6F; P , 0.05).
Next, we assessed M2 markers. In diabetes, there was
a significant increase in percentage of Arg1+ and percent-
age of CD206+ macrophages per total macrophages in WT
compared with nondiabetic mice receiving WT bone mar-
row (Fig. 6F; P , 0.01 and P , 0.05, respectively). We
found that there was a significantly higher percentage of
Arg1+ macrophages per total number of macrophages in
diabetic WT recipient mice receiving RAGE-null compared
with WT bone marrow (Fig. 6F; P , 0.001), and a trend
toward increased percentage of CD206+ macrophages in
diabetic mice receiving RAGE-null compared with WT
bone marrow. In the nondiabetic recipients of RAGE-null
compared with WT bone marrow, significantly higher
percentage of Arg1 and CD206+ macrophages were found
in the WT nondiabetic recipients of RAGE-null compared
with WT bone marrow (Fig. 6F; P , 0.01 and P , 0.05,
respectively). Analogous findings were found when the
data were analyzed by arbitrarily setting as 100% the
number of macrophages per total macrophages in the WT
nondiabetic groups (Fig. 6G).
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FIG. 5. Deletion of RAGE in bone marrow in diabetic mice restores effective axonal regeneration and improves conduction velocity after acute
sciatic nerve crush. Histological analysis of sciatic nerve myelinated fibers 21 days after acute injury in WT mice subjected to lethal irradiation and
reconstitution with the indicated bone marrow (WT or RAGE-null) followed 4 weeks later by induction of diabetes or nondiabetic state. A–E:
Unlesioned nerve at baseline. F–J: Crushed nerve 21 days postsurgery. Semithin sections reveal a significant difference in number of myelinated
fibers per mm
2
between WT mice reconstituted with RAGE-null compared with WT bone marrow in the diabetic state, indicating that trans-
plantation of RAGE-deficient bone marrow is beneficial for nerve regeneration in diabetes after injury. Scale bar: 50 mm, n = 8 mice per group.
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Taken together, the absence of RAGE expression in the
bone marrow, particularly in the diabetic state, was suffi-
cient to restore myelinated fiber density and conduction
velocity, in parallel with significantly increased M2 polar-
ization markers of macrophages in the nerve tissue post-
crush.
BMDMs and polarization: effect of AGE-RAGE. To
study macrophage polarization in vitro, we incubated
BMDMs in low (5.5 mmol/L D-glucose) compared with high
diabetes-relevant (25 mmol/L D-glucose) conditions, or
CML–human serum albumin (HSA) AGE. As shown in Fig.
7A, incubation of WT BMDMs with high glucose for 7 days
resulted in a trend to increased CD86 mRNA transcripts,
and incubation of WT BMDMs with CML-HSA AGE for 48 h
resulted in a highly significant increase in CD86 mRNA
transcripts (P , 0.001). Consistent with roles for RAGE in
regulation of CD86 by AGEs, incubation of RAGE-null
BMDMs with CML-HSA resulted in significantly lower
CD86 mRNA transcripts compared with wild-type BMDMs
(Fig. 7B; P , 0.001). There were no differences between
CD86 mRNA transcripts observed in WT BMDMs com-
pared with RAGE-null BMDMs grown in high glucose, at
least during this time course.
In the case of M2 markers, incubation of WT BMDMs
with CML-HSA AGE or with high glucose for 7 days
resulted in highly significant downregulation of Arg1
mRNA transcripts (Fig. 7C; P, 0.001). Key roles for RAGE
were identified; incubation of RAGE-null BMDMs with
CML-HSA AGE resulted in significantly higher Arg1 mRNA
transcripts compared with WT BMDMs (Fig. 7D; P , 0.05).
There were no significant effects of RAGE expression in
high-glucose-treated BMDMs (Fig. 7D) during this time
course.
DISCUSSION
Our previous studies illustrated that deletion of RAGE was
protective in murine models of long-term diabetes-associ-
ated neuropathy (14,15). Because RAGE is critically in-
volved in inflammatory mechanisms by virtue of its ability
to bind members of the S100/calgranulin family, HMGB1
and Mac-1 (19,20,36), we tested its role in superimposed
acute nerve crush injury. These studies bear clinical rele-
vance because diabetic subjects often sustain thermal and
other acute injuries to their extremities during advancing
neuropathy (7–10). This present work reveals that RAGE,
particularly in bone marrow cells and in diabetes, con-
tributes to maladaptive inflammatory mechanisms after
acute nerve crush.
Our data confirmed that diabetes was associated with
increased expression of AGEs in the peripheral nerve in
the basal state (15) and buttressed our findings that AGE
levels were lower in diabetic RAGE-null mice com-
pared with diabetic WT mice (37). We previously showed
that RAGE suppresses mRNA and protein levels of
glyoxalase-1 in murine kidney cortex in diabetic OVE26
mice (37). Glyoxalase-1 is a chief detoxification mecha-
nism that diverts the AGE precursor, methylglyoxal, from
forming long-lived AGEs (38). The finding that diabetic
RAGE-null mice displayed lower levels of CML-AGE in
the peripheral nerve in the basal state supports a key role
for RAGE in suppression of anti-AGE defense mecha-
nisms.
Our data reveal that acute injury to the sciatic nerve
dramatically increases levels of CML-AGE, irrespective
of the state of glycemia or RAGE expression. Previous
work by others suggested potential roles for the myelo-
peroxidase family of enzymes in generation of this
prevalent AGE (39). In parallel, the RAGE ligand HMGB1
also was upregulated by crush in all groups, supporting
previous findings that HMGB1 is released by damaged
cells (40). It is also possible that heretofore unidentified
ligands of RAGE may contribute to the response to nerve
crush.
Streptozotocin-treated diabetic mice remained consis-
tently diabetic (blood glucose .260 mg/dL) throughout the
course of study. By this method of induction of diabetes,
levels of insulin were not drastically reduced by strepto-
zotocin, nor were they dependent on RAGE (Supplemen-
tary Table 1). Rather, a relatively milder form of diabetes
was induced in which streptozotocin-treated mice did not
lose weight and were not ketotic. These findings are quite
analogous to our earlier studies in which we used the
identical streptozotocin regimen in mice devoid of apoli-
poprotein E to study atherosclerosis (41). In the current
study, although these experimental conditions may un-
derlie the lack of significant reduction of nerve conduction
velocities in the basal precrush state, they nevertheless
assured that the animals were not demonstrating weight
loss or ketoacidosis, distinct features that might have
confounded data interpretation.
Our data, both in the global state and after bone marrow
transplantation, reveal that the effects of RAGE deletion
are most striking in diabetes, because deletion of RAGE in
nondiabetic mice had no significant beneficial or adverse
effect on nerve fiber regeneration or restoration of con-
duction velocities. We previously showed that strategies to
decoy RAGE ligands, via administration of soluble RAGE
or introduction of a cytoplasmic tail-deleted mutant of
RAGE in peripheral neurons or mononuclear phagocytes,
reduced the regenerative response in nondiabetic mice
after acute sciatic nerve crush (23,24). Those data suggest
that ligands that may act through distinct non-RAGE
receptors may impart beneficial adaptive responses in the
absence of hyperglycemia. It was shown that upregulation
of CD36 (a non-RAGE AGE receptor) in macrophages (42),
by pioglitazone, promoted peripheral nerve remyelination
after crush injury. The authors showed that post-
pioglitazone CD36 was upregulated in the infiltrating
macrophages, suggesting that CD36 contributed to mech-
anisms that clear the injured nerve tissue of debris and
thus lead to a microenvironment ready for remyelination
and regeneration (43). Consistent with these concepts,
mice devoid of CD36 revealed delays in remyelination and
suppressed clearance of myelin by the invading and local
macrophages. By day 21 postcrush, our data revealed
significantly reduced Oil-Red-O staining in diabetic RAGE-
null compared with WT mice. These data suggest that di-
rect blockade of RAGE in the diabetic nerve is likely to be
adaptive, because ligands that might interact with distinct
non-RAGE receptors will not be detoured from their re-
generation-stimulating targets.
K–N: Nerve conduction velocity (NCV) in unlesioned nerve at baseline (K, L) and acutely injured (M, N) nerve 21 days postsciatic nerve crush.
NCV analysis 21 days postcrush indicated that conduction velocity is significantly improved in WT diabetic mice reconstituted with RAGE-null
compared with WT bone marrow; n = 15 mice per group.
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FIG. 6. Macrophage infiltration and polarization in diabetes and crush injury: effect of bone marrow RAGE expression. The indicated groups of
mice were subjected to diabetes or nondiabetes state; on day 7 after injury, tissue was retrieved and the indicated immunostaining experiments
were performed as follows. A–D: Immunofluorescence staining for F4/80 (red) and DAPI (nuclei) staining of sciatic nerve cross-section in the
indicated mouse groups 7 days after injury. Scale bar: 25 mm. E: Statistical analysis of macrophage infiltration at two different sections of the
nerve. Results are reported as total macrophage number per ROI as determined by F4/80 staining. F: Invading macrophages were stained for M1
and M2 markers (M1, CD86, and iNOS) and (M2, Arg1, and CD206). Results are depicted as the percent of total macrophages costained for in-
dividual markers. G: Results are depicted by setting the WT nondiabetic condition as 100% for reference and all other groups compared with this
condition; n = 6 mice per condition. (A high-quality digital representation of this figure is available in the online issue.)
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We were intrigued by the finding that, in general, RAGE-
null nerve tissue postcrush displayed either significantly
higher numbers of macrophages (perineurium) or no re-
duction in the numbers of macrophages (crush and distal
sites) compared with the respective RAGE-expressing
groups. These findings, together with the demonstrated
benefit of deletion of RAGE in the bone marrow, led us to
query whether the properties of the macrophages differed
by glycemia or RAGE expression status. Although cer-
tainly a complex area of biology, it is known that discrete
classes of macrophages contribute to a greater degree to
active inflammation mechanisms (M1), whereas others
play more pronounced roles in repair and regeneration
(M2). Individual macrophages may express both M1 and
M2 markers; hence, it may be the “balance” of expression
of these markers that facilitates sustained inflammation or
upregulation of repair and resolution mediators. In global
RAGE-null mice and in WT mice reconstituted with RAGE-
deficient bone marrow and subjected to nerve crush, par-
ticularly in the diabetic state, a consistent finding was that
FIG. 7. RAGE modulates macrophage polarization in BMDMs: effect of glucose and AGE. BMDMs were retrieved from the indicated mice and
incubated for 7 days with low physiologic levels of glucose (5.5 mmol/L D-glucose) or high glucose (diabetes-relevant) (25 mmol/L D-glucose). In
other studies, BMDMs were incubated in physiologic levels of glucose (5.5 mmol/L D-glucose) and CML-HSA (100 mg/mL) for 48 h. Macrophages
were retrieved and subjected to real-time quantitative PCR. A and C: The effects of glucose and AGEs on WT BMDM expression of CD86 and Arg1
(respectively) are shown. WT low-glucose incubated BMDMs were set as reference. B and D: The effects of RAGE deletion on glucose and CML-
HSA treatment on expression of CD86 and Arg1 (respectively) are shown. WT macrophages exposed to AGE (CML-HSA) are set as the reference.
This experiment was repeated for a total of three independent experiments.
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deletion of RAGE resulted in higher expression of M2
markers, Arg1, and CD206. In the nondiabetic state, de-
letion of bone marrow RAGE in WT mice also increased
Arg1 M2 marker. There was no consistent pattern of RAGE
expression with M1 marker expression, suggesting that the
principal benefits of RAGE deletion in nerve regeneration
were not accounted for in significant measure by changes
in M1 macrophage markers. Our studies in isolated
BMDMs confirmed that deletion of RAGE in CML-AGE–
treated macrophages resulted in higher expression of Arg1
compared with corresponding WT macrophages under the
same conditions. Consistent with this concept, diabetic
RAGE-null mice postcrush exhibited increased numbers of
endoneurial vessels and regenerating axons and reduced
Oil-Red-O staining by day 21, all features linked to repair
and regeneration.
Previous studies by Kennedy and Zochodne showed that
macrophage responses in diabetic peripheral nerve after
superimposed crush in rats were impaired; those authors
speculated that reduced macrophage function might con-
tribute to impaired Wallerian degeneration, a prerequisite
to effective axonal regeneration (13). Terada et al. (44)
tested these concepts in a murine model of diabetes and
sciatic nerve transection. They showed that Wallerian de-
generation was significantly delayed in the diabetic com-
pared with the nondiabetic nerve, but the mechanisms by
which macrophage properties were impacted were not
studied (44). Nevertheless, these previous studies sug-
gested that peripheral nerve regeneration in diabetic mice
with superimposed acute nerve damage was impaired, at
least in part via delayed and less effective Wallerian de-
generation, a process that requires effective macrophage
function and a balance between proinflammatory and
tissue-restorative activities. Our data provide a mechanis-
tic explanation for these findings. We may deduce that M1
macrophage responses in the injured nerve segments must
be counterbalanced by reparative M2 responses to facili-
tate clearance of myelin debris with the generation of an
environment conducive for nerve fiber regeneration.
Recently, Parathath et al. (45) showed that in hyper-
lipidemic, atherosclerosis-vulnerable mice, diabetes slowed
regression of atherosclerosis. The authors noted that di-
abetes skewed macrophage polarization toward the M1
compared with the M2 phenotype (45) and that lesional
collagen content, usually linked to plaque stability and less
inflammation, was reduced in the diabetic plaques. Because
collagen formation is typically associated with M2 polariza-
tion (46), these data suggest that M1 macrophage polariza-
tion may have contributed, at least in part, to sustained
proinflammatory forces and reduced regression.
In conclusion, our data reveal that RAGE-dependent
reduction in M2 polarization in the diabetic peripheral
nerve after acute nerve crush, at least in part by bone
marrow-derived RAGE-expressing cells, is linked to im-
paired axonal regeneration and reduced recovery of con-
duction velocities. We show that RAGE may contribute to
altered polarization and that global or selective bone
marrow deletion of RAGE in diabetes enhances M2 mac-
rophage polarization and nerve regeneration consequent
to acute injury.
Finally, these data are consistent with our recent work
showing quite diverse roles for Myd88 compared with
RAGE in survival and regeneration responses in massive
liver injury (22). We conclude that RAGE is not critical for
innate repair responses in the acutely injured diabetic
nerve, and surmise that blocking the chronic maladaptive
effects of inflammatory cell RAGE signaling in this setting
may contribute to prevention of long-term damage and to
the mediation of effective acute responses to injury via
restoration of adaptive macrophage responses.
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